The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Final randomized Phase 2 Bria-IMT™ survival and quality of life data to be presented Biomarker analyses from the ongoing Phase 3 study evaluating ...

The first half of this year has been riddled with market volatility and geopolitical tension. But 2025’s American Society of Clinical Oncology conference largely isn’t reflecting that turmoil. In fact ...

The new data could support a broader approval submission for a therapy that is already under review and set to be showcased ...

View all available purchase options and get full access to this article. This Q&A is derived from recommendations in Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline. This document is ...

Recent updates put the utility of Summit Therapeutics's ivonescimab into question as a frontline therapy. Click here to read ...

Thousands of cancer researchers and clinicians are flocking to Chicago for the American Society of Clinical Oncology annual meeting that starts Friday. The ASCO meeting is where clinicians expect to ...

At ASCO 2025, pharmaphorum web editor Nicole Raleigh sat down to discuss key highlights from the Congress with EVERSANA experts. With Tim Lewis, EVP, Strategic Development, Oncology and Precision ...

Color today announced that its Virtual Cancer Clinic, powered by Color Medical's 50-state, oncologist-led medical group, has become the first virtual practice to earn ASCO Certified status, a ...